Mark Chin has 15 years of healthcare experience in venture capital, consulting, and corporate development. He currently serves as an Investment Partner at Avoro Ventures, having previously held roles at Arix Bioscience, Longitude Capital, Boston Consulting Group, Gilead Sciences, and Genentech.
What Mark can write
Avoro Ventures writes $30M and up checks, larger than 99% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Avoro Ventures.Career
- Genentech · market planning
- Gilead Sciences · corporate development
- Boston Consulting Group · consultant
- Longitude Capital · Principal
- Arix Bioscience · Managing Director
- Avoro Ventures · Investment PartnerNow
- Avoro Ventures · PartnerNow
Focus
Also at Avoro Ventures
Partners like Mark
At firms with a similar stage, sector and check size.
Alert me when Avoro Ventures is active
One email when Mark's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Mark Chin?
Mark Chin has 15 years of healthcare experience in venture capital, consulting, and corporate development. He currently serves as an Investment Partner at Avoro Ventures, having previously held roles at Arix Bioscience, Longitude Capital, Boston Consulting Group, Gilead Sciences, and Genentech.
How much does Mark Chin invest?
Mark Chin invests through Avoro Ventures, which writes checks of $30M and up at series b.
How do I pitch Mark Chin?
Email [email protected], the firm's inbox for founders, and name Mark in the subject. A warm intro from a founder Avoro Ventures backed works better.
What did Mark Chin do before Avoro Ventures?
market planning at Genentech; corporate development at Gilead Sciences; consultant at Boston Consulting Group; Principal at Longitude Capital; Managing Director at Arix Bioscience.
Last updated 2026-10-15. Is this you? Ask for a correction.